1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY.
Global data on blindness. Bull World Health Organ 1995;
73: 115-121.
2. Pauleikhoff D. Neovascular age-related macular degeneration. Natural history and treatment outcomes. Retina
2005; 25: 1065-1084.
3. Sickenberg M. Early detection, diagnosis and management of choroidal neovascularization in age-related macular degeneration: the role of ophthalmologists.
Ophthalmologica 2001; 215: 247-253.
4. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic
therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin. One-year
result of 2 randomized clinical trials-TAP Report 1. Arch
Ophthmol 1999; 117: 1329-1345.
5. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H.
Photodynamic effects on choroidal neovascularization
and physiological choroid. Invest Ophthalmol Vis Sci
2002; 43: 830-841.
6. Blinder KJ, Blumenkranz MS, Bressler NM, et al.
Verteporfin in photodynamic therapy (VIP) study group.
Verteporfin therapy of subfoveal choroidal neovascularization pathologic myopia: two-year results of a randomized clinical trial. VIP report 3. Ophthalmology 2003; 110:
667-673.
7. Yetik H, Müftüoðlu G, Akar S, Aras C, Özkan Þ. Oküler
fotodinamik tedavide 24 aylýk sonuçlarýmýz. Retina
Vitreus 2005; 13: 173-178.
8. Karaçorlu M, Karaçorlu S, Özdemir H. Klasik koroid
neovaskülarizasyonlu ve gizli koroid neovaskülarizasyonlu yaþa baðlý makula dejenerasyonu olgularýndaki fotodinamik tedavi uygulamasýnýn 12 aylýk takip sonuçlarý.
Retina Vitreus 2003; 11: 13-18.
9. Altan T, Kapran Z, Yalçýn O, Acar N, Çakýr M, Ünver
YB. Yaþa baðlý makula dejenerasyonununda subfoveal
koroidal neovaskülarizasyonunu vertoporfin ile fotodinamik tedavisinin orta ve uzun dönem sonuçlarý. Retina
Vitreus 2006; 14: 169-174.
10. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year
incidence and progression of age-related maculopathy:
the Beaver Dam Eye Study. Ophthalmology 1997; 104: 7-
21.
11. Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER.
Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology
2004; 111: 250-255.
Tablo IV. Lezyon tiplerine göre görme keskinliði deðiþiklikleri
_________________________________________________________________________________________________________________
Aðýr görme Orta görme Hafif görme Görme keskinliði Görme keskinliði
Lezyon tipi keskinliði kaybý keskinliði kaybý keskinliði kaybý ayný kalan artan Toplam
n (%) n (%) n (%) n (%) n (%) n (%)
_________________________________________________________________________________________________________________
Baskýn klasik 0 (0.0) 3 (8.8) 7 (20.5) 11 (32.3) 13 (38.2) 34 (100.0)
Minimal klasik 0 (0.0) 0 (0.0) 2 (14.2) 6 (42.8) 6 (42.8) 14 (100.0)
Gizli 2 (7.4) 3 (11.1) 5 (18.5) 9 (33.2) 8 (29.6) 27 (100.0)
_________________________________________________________________________________________________________________
Toplam 2 (2.6) 6 (8.0) 14 (18.7) 26 (34.7) 27 (36.0) 75 (100.0)
_________________________________________________________________________________________________________________244 · Aralýk 2007 · Gülhane TD Sakýn ve ark.
12. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic
therapy of subfoveal choroidal neovascularization in agerelated macular degeneration with Verteporfin. Two-year
results of 2 randomized clinical trials. TAP report 2. Arch
Ophthalmol 2001; 119: 198-207.
13. Blumenkranz MS, Bressler NM, Bressler SB, et al.
Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration Three-year results of an open
label extension of 2 randomized clinical trials. TAP report
5. Arch Ophthalmol 2002; 120: 1307-1314.
14. Palamer M, Akýn C, Afrashi F, Erakgün T, Eðrilmez S,
Menteþ J. Eksüdatif yaþa baðlý makula dejeneresansýnýn
doðal seyrinde geliþen skar ile fotodinamik tedavi sonrasý
geliþen skarlarýn karþýlaþtýrýlmasý. T Oft Gaz 2007; 37:
286-292.
Thank you for copying data from http://www.arastirmax.com